A novel prognostic score (HAMP) for head and neck cancer patients with single and multiple SBRT‐treated lung metastases derived from retrospective analyses of survival outcome.

Bibliographic Details
Title: A novel prognostic score (HAMP) for head and neck cancer patients with single and multiple SBRT‐treated lung metastases derived from retrospective analyses of survival outcome.
Authors: Vorbach, Samuel M., Seppi, Thomas, Sarcletti, Manuel P., Kollotzek, Siegfried, Mangesius, Julian, Lehmann, Jens, Riedl, David, Pointner, Martin J., Santer, Matthias, Dejaco, Daniel, Nevinny‐Stickel, Meinhard, Ganswindt, Ute
Source: Head & Neck; Jan2025, Vol. 47 Issue 1, p242-253, 12p
Subject Terms: HEAD & neck cancer, STEREOTACTIC radiotherapy, OVERALL survival, PROGNOSIS, SURVIVAL rate
Abstract: Background: We report on the characterization and introduction of a novel prognostic score for patients undergoing stereotactic body radiotherapy (SBRT) for the treatment of single and multiple pulmonary metastases (PMs) derived from head and neck cancer (HNC). Methods: In this retrospective study, we examined selected factors associated with progression‐free survival (PFS) and overall survival (OS) among 59 patients with HNC treated with SBRT for a total of 118 PMs, between 2009 and 2023. Factors related to survival were included in the prognostic scoring system. Results: Prognostic factors including histology, age, number of metastases, and performance status at first SBRT were weighted differently depending on the strength of correlation to PFS and OS. Total prognostic scores (HAMP) ranged from 13 to 24 points, with a cut‐off total score of ≤18 scoring points for patients in a high‐risk (HR) subcohort, and of ≥19 scoring points for patients in a low‐risk group (LR). Median PFS (23.8 vs. 5.5 months, p < 0.001) and OS (61.3 vs. 16.4 months, p < 0.001) were significantly longer in the low‐risk group compared to the high‐risk group. Conclusion: The HAMP score might be a convenient tool to facilitate individualized treatment decisions and appropriate follow‐up. The accuracy and reliability of the score requires further evaluation in prospective studies. [ABSTRACT FROM AUTHOR]
Copyright of Head & Neck is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:10433074
DOI:10.1002/hed.27913
Published in:Head & Neck
Language:English